These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 37863180)

  • 1. Commentary: Neoadjuvant immunotherapy followed by lung cancer resection: Is the future already here?
    Reddy RM
    J Thorac Cardiovasc Surg; 2024 Jun; 167(6):1908-1909. PubMed ID: 37863180
    [No Abstract]   [Full Text] [Related]  

  • 2. Induction therapy for non-small cell lung cancer.
    Cooper A; Chaft JE; Bott MJ
    J Thorac Cardiovasc Surg; 2024 Aug; 168(2):411-416. PubMed ID: 38354767
    [No Abstract]   [Full Text] [Related]  

  • 3. Management of stage IIIA non-small cell lung cancer by thoracic surgeons in North America.
    Veeramachaneni NK; Feins RH; Stephenson BJ; Edwards LJ; Fernandez FG
    Ann Thorac Surg; 2012 Sep; 94(3):922-6; discussion 926-8. PubMed ID: 22742842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Promise of Neoadjuvant Immunotherapy in Resected Non-small Cell Lung Cancer].
    Yao S; Zhang Y
    Zhongguo Fei Ai Za Zhi; 2020 Jan; 23(1):55-59. PubMed ID: 31948539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pneumonectomy: calculable or non-tolerable risk factor in trimodal therapy for Stage III non-small-cell lung cancer?
    Steger V; Spengler W; Hetzel J; Veit S; Walker T; Mustafi M; Friedel G; Walles T
    Eur J Cardiothorac Surg; 2012 Apr; 41(4):880-5; discussion 885. PubMed ID: 22233799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NEOSTAR trial and the current status of neoadjuvant therapy in non-small cell lung cancer.
    Sepesi B; Mehran R; Spicer J; Cascone T
    J Thorac Cardiovasc Surg; 2024 Jun; 167(6):1936-1942. PubMed ID: 37923289
    [No Abstract]   [Full Text] [Related]  

  • 7. Discussion to: Lung resection after initial nonoperative treatment for non-small cell lung cancer.
    J Thorac Cardiovasc Surg; 2024 Aug; 168(2):374-375. PubMed ID: 38149952
    [No Abstract]   [Full Text] [Related]  

  • 8. Discussion to: Induction chemoimmunotherapy with surgery versus concurrent chemoradiation followed by immunotherapy for stage III-N2 non-small cell lung cancer.
    J Thorac Cardiovasc Surg; 2024 Jun; 167(6):1906-1907. PubMed ID: 38032558
    [No Abstract]   [Full Text] [Related]  

  • 9. A Pathologic Complete Response to Neoadjuvant Chemotherapy and Immunotherapy Followed by Surgery in a Patient With NSCLC.
    Ma X; Li B; Li Y; Lu L; Chen H
    J Thorac Oncol; 2019 May; 14(5):e104-e106. PubMed ID: 31027744
    [No Abstract]   [Full Text] [Related]  

  • 10. Pneumonectomy is a valuable treatment option after neoadjuvant therapy for stage III non-small-cell lung cancer.
    Weder W; Collaud S; Eberhardt WE; Hillinger S; Welter S; Stahel R; Stamatis G
    J Thorac Cardiovasc Surg; 2010 Jun; 139(6):1424-30. PubMed ID: 20416887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Our experience with patients operated after neoadjuvant therapy].
    Juhász M; Egri G; Váradi C; Mészáros Z; Keszler P
    Magy Seb; 2004 Dec; 57(6):332-5. PubMed ID: 15803876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pneumonectomy for Clinical Stage IIIA Non-Small Cell Lung Cancer: The Effect of Neoadjuvant Therapy.
    Broderick SR; Patel AP; Crabtree TD; Bell JM; Morgansztern D; Robinson CG; Kreisel D; Krupnick AS; Patterson GA; Meyers BF; Puri V
    Ann Thorac Surg; 2016 Feb; 101(2):451-7; discussion 457-8. PubMed ID: 26410162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perioperative considerations for neoadjuvant immunotherapy in non-small cell lung cancer.
    Stiles BM; Sepesi B; Broderick SR; Bott MJ
    J Thorac Cardiovasc Surg; 2020 Nov; 160(5):1376-1382. PubMed ID: 32763029
    [No Abstract]   [Full Text] [Related]  

  • 14. Re: Randomized controlled trial of resection versus radiotherapy after induction chemotherapy in stage IIIA-N2 non small-cell lung cancer.
    Leo F; De Pas T; Catalano G; Piperno G; Curigliano G; Solli P; Veronesi G; Petrella F; Spaggiari L
    J Natl Cancer Inst; 2007 Aug; 99(15):1210; author reply 1210-1. PubMed ID: 17652281
    [No Abstract]   [Full Text] [Related]  

  • 15. Anatomical lung resection after neoadjuvant chemoradiotherapy.
    Burrows WM
    Semin Thorac Cardiovasc Surg; 2007; 19(4):360-5. PubMed ID: 18395639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. eComment: Defective bronchial tissue homeostasis following neoadjuvant therapy for lung cancer.
    Walles T; Hampel M; Dally I; Friedel G
    Interact Cardiovasc Thorac Surg; 2009 Oct; 9(4):575. PubMed ID: 19773233
    [No Abstract]   [Full Text] [Related]  

  • 17. [Progress in Neoadjuvant Immunotherapies for Resectable Non-small Cell Lung Cancer].
    Wang S; Mao Y
    Zhongguo Fei Ai Za Zhi; 2020 May; 23(5):371-380. PubMed ID: 32283581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Preliminary Efficacy Evaluation of Neoadjuvant Immunotherapy Combined with 
Chemotherapy in Resectable Non-small Cell Lung Cancer].
    Zhou S; Hao X; Yu D; Liu S; Cao X; Su C; Song X; Xiao N; Li Y; Yang W; Zhao D; Wang J; Liu Z; Xu S
    Zhongguo Fei Ai Za Zhi; 2021 Jun; 24(6):420-425. PubMed ID: 34024062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The surgical perspective in neoadjuvant immunotherapy for resectable non-small cell lung cancer.
    Jiang L; Huang J; Jiang S; Rong W; Shen Y; Li C; Tian Y; Ning J; Chen X; Yang Y; Ding Z; Li Z; Luo Q
    Cancer Immunol Immunother; 2021 Aug; 70(8):2313-2321. PubMed ID: 33512555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical outcomes associated with neoadjuvant therapy for the treatment of resectable non-small cell lung cancer in real-world practice.
    Huang X; Pang G; Mao Z; Li B; Teng Z; Yang Y; Qiu Z; Chen X; Wang P
    Clin Respir J; 2024 May; 18(5):e13761. PubMed ID: 38693705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.